Literature DB >> 16844909

Upregulation of proteinase-activated receptors and hypercontractile responses precede development of arterial lesions after balloon injury.

Ryota Fukunaga1, Katsuya Hirano, Mayumi Hirano, Naohisa Niiro, Junji Nishimura, Yoshihiko Maehara, Hideo Kanaide.   

Abstract

Thrombin and other proteinases exert vascular effects by activating the proteinase-activated receptors (PARs). The expression of PARs has been shown to be upregulated after balloon injury and in human arteriosclerosis. However, the relationship between the receptor upregulation and the alteration of vasomotor function remains to be elucidated. We herein demonstrated that the contractile responses to the PAR-1 and PAR-2 agonist were markedly enhanced in the rabbit femoral arteries after balloon injury. Neointimal thickening was established 4 wk after the injury. No histological change was observed in the sham operation, where the saphenous artery was ligated without any balloon injury. The contractile response to K(+) depolarization was significantly attenuated 1 wk after the injury and then partly recovered after 4 wk. Thrombin, PAR-1-activating peptide, trypsin, and PAR-2-activating peptide induced no significant contraction in the control. All these stimulants induced enhanced responses 1 wk after balloon injury. Such enhanced responses were seen 4 wk after the injury, except for thrombin. There was no change in the Ca(2+) sensitivity of the contractile apparatus as evaluated in the permeabilized preparations. PAR-1-activating peptide (100 mumol/l), but no other stimulants, induced an enhanced contraction in the sham operation. The expression of PAR-1 and PAR-2 slightly increased after the sham operation, whereas it markedly and significantly increased after balloon injury. Our observations suggest that balloon injury induced the receptor upregulation, thereby enhancing the contractile response before the establishment of vascular lesions. The local inflammation associated with the sham operation may also contribute to the receptor upregulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844909     DOI: 10.1152/ajpheart.01313.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  6 in total

1.  Thrombin activation of proteinase-activated receptor 1 potentiates the myofilament Ca2+ sensitivity and induces vasoconstriction in porcine pulmonary arteries.

Authors:  Jun Maki; Mayumi Hirano; Sumio Hoka; Hideo Kanaide; Katsuya Hirano
Journal:  Br J Pharmacol       Date:  2010-01-28       Impact factor: 8.739

2.  Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage.

Authors:  Y Maeda; K Hirano; Y Kai; M Hirano; S O Suzuki; T Sasaki; H Kanaide
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

Review 3.  Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.

Authors:  Frank Gieseler; Hendrik Ungefroren; Utz Settmacher; Morley D Hollenberg; Roland Kaufmann
Journal:  Cell Commun Signal       Date:  2013-11-11       Impact factor: 5.712

4.  Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis.

Authors:  Corey S Moran; Sai-Wang Seto; Smriti M Krishna; Surabhi Sharma; Roby J Jose; Erik Biros; Yutang Wang; Susan K Morton; Jonathan Golledge
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

5.  Arterial response to shear stress critically depends on endothelial TRPV4 expression.

Authors:  Veronika Hartmannsgruber; Willm-Thomas Heyken; Michael Kacik; Anuradha Kaistha; Ivica Grgic; Christian Harteneck; Wolfgang Liedtke; Joachim Hoyer; Ralf Köhler
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

6.  Blood pressures, heart rate and locomotor activity during salt loading and angiotensin II infusion in protease-activated receptor 2 (PAR2) knockout mice.

Authors:  John J McGuire; Bruce N Van Vliet; Sarah J Halfyard
Journal:  BMC Physiol       Date:  2008-10-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.